首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Safety Versus Tolerability
被引:7
|
作者
:
Shader, Richard I.
论文数:
0
引用数:
0
h-index:
0
Shader, Richard I.
机构
:
来源
:
CLINICAL THERAPEUTICS
|
2018年
/ 40卷
/ 05期
关键词
:
D O I
:
10.1016/j.clinthera.2018.04.003
中图分类号
:
R9 [药学];
学科分类号
:
1007 ;
摘要
:
引用
收藏
页码:672 / 673
页数:2
相关论文
共 50 条
[21]
Safety and tolerability of ertapenem
Teppler, H
论文数:
0
引用数:
0
h-index:
0
机构:
Merck Res Labs, W Point, PA USA
Merck Res Labs, W Point, PA USA
Teppler, H
Gesser, RM
论文数:
0
引用数:
0
h-index:
0
机构:
Merck Res Labs, W Point, PA USA
Merck Res Labs, W Point, PA USA
Gesser, RM
Friedland, IR
论文数:
0
引用数:
0
h-index:
0
机构:
Merck Res Labs, W Point, PA USA
Merck Res Labs, W Point, PA USA
Friedland, IR
Woods, GL
论文数:
0
引用数:
0
h-index:
0
机构:
Merck Res Labs, W Point, PA USA
Merck Res Labs, W Point, PA USA
Woods, GL
Meibohm, A
论文数:
0
引用数:
0
h-index:
0
机构:
Merck Res Labs, W Point, PA USA
Merck Res Labs, W Point, PA USA
Meibohm, A
Herman, G
论文数:
0
引用数:
0
h-index:
0
机构:
Merck Res Labs, W Point, PA USA
Merck Res Labs, W Point, PA USA
Herman, G
Mistry, G
论文数:
0
引用数:
0
h-index:
0
机构:
Merck Res Labs, W Point, PA USA
Merck Res Labs, W Point, PA USA
Mistry, G
Isaacs, R
论文数:
0
引用数:
0
h-index:
0
机构:
Merck Res Labs, W Point, PA USA
Merck Res Labs, W Point, PA USA
Isaacs, R
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY,
2004,
53
: 75
-
81
[22]
Bisphosphonate safety and tolerability
Body, JJ
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Libre Bruxelles, Inst Jules Bordet, Dept Internal Med, Brussels, Belgium
Univ Libre Bruxelles, Inst Jules Bordet, Dept Internal Med, Brussels, Belgium
Body, JJ
ONCOLOGIST,
2005,
10
(05):
: 317
-
317
[23]
Safety and tolerability of omalizumab
Corren, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Allergy Res Fdn, Los Angeles, CA 90025 USA
Corren, J.
Casale, T. B.
论文数:
0
引用数:
0
h-index:
0
机构:
Allergy Res Fdn, Los Angeles, CA 90025 USA
Allergy Res Fdn, Los Angeles, CA 90025 USA
Casale, T. B.
Lanier, B.
论文数:
0
引用数:
0
h-index:
0
机构:
Lanier Educ & Res Network, Ft Worth, TX USA
Allergy Res Fdn, Los Angeles, CA 90025 USA
Lanier, B.
Buhl, R.
论文数:
0
引用数:
0
h-index:
0
机构:
Mainz Univ Hosp, Dept Pulm, Mainz, Germany
Allergy Res Fdn, Los Angeles, CA 90025 USA
Buhl, R.
Holgate, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Southampton Gen Hosp, Southampton SO9 4XY, Hants, England
Allergy Res Fdn, Los Angeles, CA 90025 USA
Holgate, S.
Jimenez, P.
论文数:
0
引用数:
0
h-index:
0
机构:
Novartis Pharmaceut, E Hanover, NJ USA
Allergy Res Fdn, Los Angeles, CA 90025 USA
Jimenez, P.
CLINICAL AND EXPERIMENTAL ALLERGY,
2009,
39
(06):
: 788
-
797
[24]
Safety and tolerability of eprosartan
Gavras, I
论文数:
0
引用数:
0
h-index:
0
机构:
Boston Univ, Sch Med, Hypertens & Atherosclerosis Sect, Dept Med, Boston, MA 02118 USA
Boston Univ, Sch Med, Hypertens & Atherosclerosis Sect, Dept Med, Boston, MA 02118 USA
Gavras, I
Gavras, H
论文数:
0
引用数:
0
h-index:
0
机构:
Boston Univ, Sch Med, Hypertens & Atherosclerosis Sect, Dept Med, Boston, MA 02118 USA
Boston Univ, Sch Med, Hypertens & Atherosclerosis Sect, Dept Med, Boston, MA 02118 USA
Gavras, H
PHARMACOTHERAPY,
1999,
19
(04):
: 102S
-
107S
[25]
THE SAFETY AND TOLERABILITY OF QUINAPRIL
KNAPP, LE
论文数:
0
引用数:
0
h-index:
0
机构:
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, MI
KNAPP, LE
FRANK, GJ
论文数:
0
引用数:
0
h-index:
0
机构:
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, MI
FRANK, GJ
MCLAIN, R
论文数:
0
引用数:
0
h-index:
0
机构:
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, MI
MCLAIN, R
RIEGER, MM
论文数:
0
引用数:
0
h-index:
0
机构:
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, MI
RIEGER, MM
POSVAR, E
论文数:
0
引用数:
0
h-index:
0
机构:
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, MI
POSVAR, E
SINGER, R
论文数:
0
引用数:
0
h-index:
0
机构:
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, MI
SINGER, R
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY,
1990,
15
: S47
-
S55
[26]
Safety and tolerability of duloxetine
Wohlreich, MM
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA
Eli Lilly & Co, Indianapolis, IN 46285 USA
Wohlreich, MM
Kajdasz, DK
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA
Eli Lilly & Co, Indianapolis, IN 46285 USA
Kajdasz, DK
Mallinckrodt, CH
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA
Eli Lilly & Co, Indianapolis, IN 46285 USA
Mallinckrodt, CH
Watkin, JG
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA
Eli Lilly & Co, Indianapolis, IN 46285 USA
Watkin, JG
Martynov, OV
论文数:
0
引用数:
0
h-index:
0
机构:
Eli Lilly & Co, Indianapolis, IN 46285 USA
Eli Lilly & Co, Indianapolis, IN 46285 USA
Martynov, OV
EUROPEAN NEUROPSYCHOPHARMACOLOGY,
2004,
14
: S205
-
S206
[27]
Safety and tolerability of plasma
Zwick, Y.
论文数:
0
引用数:
0
h-index:
0
Zwick, Y.
HAMOSTASEOLOGIE,
2010,
30
(03):
: 171
-
171
[28]
TOLERABILITY SAFETY OF ANTIDEPRESSANTS
不详
论文数:
0
引用数:
0
h-index:
0
不详
JOURNAL OF CLINICAL PSYCHIATRY,
1994,
55
(06)
: 272
-
273
[29]
TOLERABILITY AND SAFETY OF FELODIPINE
ELVELIN, L
论文数:
0
引用数:
0
h-index:
0
机构:
ASTRA HASSLE AB, DEPT CARDIOVASC MED, S-43183 MOLNDAL, SWEDEN
ASTRA HASSLE AB, DEPT CARDIOVASC MED, S-43183 MOLNDAL, SWEDEN
ELVELIN, L
KENNERFALK, A
论文数:
0
引用数:
0
h-index:
0
机构:
ASTRA HASSLE AB, DEPT CARDIOVASC MED, S-43183 MOLNDAL, SWEDEN
ASTRA HASSLE AB, DEPT CARDIOVASC MED, S-43183 MOLNDAL, SWEDEN
KENNERFALK, A
ELMFELDT, D
论文数:
0
引用数:
0
h-index:
0
机构:
ASTRA HASSLE AB, DEPT CARDIOVASC MED, S-43183 MOLNDAL, SWEDEN
ASTRA HASSLE AB, DEPT CARDIOVASC MED, S-43183 MOLNDAL, SWEDEN
ELMFELDT, D
CARDIOVASCULAR DRUG REVIEWS,
1993,
11
(01):
: 126
-
147
[30]
Safety and tolerability of rizatriptan
Sakai, F
论文数:
0
引用数:
0
h-index:
0
机构:
Kitasato Univ, Dept Med, Kanagawa, Japan
Kitasato Univ, Dept Med, Kanagawa, Japan
Sakai, F
CEPHALALGIA,
2000,
20
: 16
-
18
←
1
2
3
4
5
→